title: Etanercept or infliximab for psoriasis? An independent randomized clinical trial.
authors.affiliation: Department of Dermatology, Royal Infirmary of Edinburgh, Lauriston Building, Edinburgh, U.K.|Institute of Infection, Inflammation and Immunity, University of Glasgow, Glasgow, U.K.
authors.forename: A D
authors.identifier: 0000-0001-7395-9931
authors.initials: AD
authors.lastname: Burden
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G; D000069285:Infliximab; D011565:Psoriasis; D018124:Receptors, Tumor Necrosis Factor
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000069285:Infliximab; D000068879:Adalimumab; D000068800:Etanercept